ClinicalTrials.Veeva

Menu

The Effect of Midazolam Premedication on Copeptine Concentration in Blood

M

Medical University of Warsaw

Status and phase

Completed
Phase 4

Conditions

Preanesthetic Medication
Copeptin

Treatments

Other: Placebo Oral Tablet
Drug: Midazolam Oral Tablet

Study type

Interventional

Funder types

Other

Identifiers

NCT03474939
MIDPRECOP

Details and patient eligibility

About

The study aim is to assess whether premedication with midazolam prior to surgery affects copeptin concentration in blood.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients scheduled for elective surgery
  • Patients with no chronić illness and considered ASA 1 by anesthesiologist
  • Patients with mild and controlled chronic illness considered ASA 2 by anesthesiologist

Exclusion criteria

  • Patient refusal
  • Chronic illness requiring intense treatment or uncontrolled illness (ASA 3 or more)

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups, including a placebo group

MIDAZOLAM
Active Comparator group
Description:
Patients receive midazolam 7,5mg night before and 60 minutes prior to surgery as part of preanesthetic medication
Treatment:
Drug: Midazolam Oral Tablet
PLACEBO
Placebo Comparator group
Description:
Patients receive 1000mg Glucose tablets night before and 60 minutes prior to surgery during premedication
Treatment:
Other: Placebo Oral Tablet

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems